Medicenna Therapeutics Co... (MDNA)

AI Score

Unlock

0.16

0.00 (1.91%)

At close: Jan 16, 2025, 9:00 PM

Medicenna Therapeutics Income Statement

Financials in CAD. Fiscal year is April - March.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-22.58M	-22.88M	-21.64M	-22.98M	-19.59M	-20.75M	-22.3M	-24.84M	-25.03M	-20.62M	-17.19M	-14.24M	-11.49M	-9.51M	-8.21M	-6.67M	-5.96M	-4.97M	-4.75M	-4.94M	-5.41M	-6.21M	-7.38M	-10.43M	-10.48M	-8.8M	-6.58M	-2.24M	-26.18K	-177.16K	-181.27K	-172.44K	-171.87K	-14.76K
Interest Income	1.41M	1.23M	914K	541K	217K	76K	69K	87K	117K	191K	313.86K	293.58K	247.58K	152.58K	6.73K	n/a	1.00	1.00	93.00	93.00	468.00	911.00	3.12K	23.94K	29.99K	29.55K	27.25K	6.43K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-11.58M	-8.76M	-10.05M	-9.4M	-13.06M	-20.35M	-22.58M	-25.18M	-25.72M	-21.32M	-17.29M	-14.16M	-11.22M	-9.33M	-8.28M	-6.64M	-5.97M	-4.96M	-4.71M	-4.97M	-5.43M	-6.25M	-7.47M	-10.51M	-10.51M	-8.81M	-6.56M	-2.22M	-43.68K	-183.89K	-187.99K	-172.44K	-171.87K	-14.76K
Net Income	-14.07M	-11.41M	-12.7M	-9.9M	-13.23M	-20.35M	-22.58M	-25.18M	-25.72M	-21.32M	-17.29M	-14.16M	-11.22M	-9.33M	-8.28M	-6.64M	-5.97M	-4.96M	-4.71M	-4.97M	-5.43M	-6.25M	-7.47M	-10.51M	-10.51M	-8.81M	-6.56M	-2.22M	-43.68K	-183.89K	-187.99K	-172.44K	-171.87K	-14.76K
Selling & General & Admin	7.31M	6.72M	6.99M	7.54M	7.54M	7.78M	7.72M	7.76M	7.87M	7.61M	6.48M	5.03M	3.68M	2.63M	2.49M	2.5M	2.32M	2.19M	2.16M	2.22M	2.66M	2.95M	3M	4.89M	4.51M	3.71M	3.11M	645.59K	25.65K	176.63K	180.74K	171.91K	171.87K	14.76K
Research & Development	10.48M	9.71M	9.3M	8.91M	8.87M	12.78M	14.72M	17.23M	17.5M	13.41M	10.87M	9.3M	7.78M	6.85M	5.87M	4.4M	4.01M	3.21M	3.02M	3.22M	3.3M	3.92M	5.09M	6.27M	6.52M	5.45M	3.64M	1.6M	618.36	618.36	618.36	618.36	n/a	n/a
Other Expenses	3K	5K	5K	4K	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-10.78K	-10.78K	-17.51K	-17.51K	-6.73K	-6.73K	n/a	n/a	n/a
Operating Expenses	17.79M	16.43M	16.3M	16.46M	16.43M	20.59M	22.47M	25.06M	25.43M	21.07M	17.4M	14.35M	11.48M	9.5M	8.24M	6.66M	5.97M	4.97M	4.73M	4.96M	5.42M	6.23M	7.42M	10.49M	10.54M	8.84M	6.61M	2.25M	26.18K	177.16K	181.27K	172.44K	171.87K	14.76K
Interest Expense	2.49M	2.65M	2.65M	502K	162K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	29.00	29.00	29.00	29.00	0.25	0.25	0.25	0.25	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.79M	16.43M	16.3M	16.46M	16.43M	20.59M	22.47M	25.06M	25.43M	21.07M	17.4M	14.35M	11.48M	9.5M	8.24M	6.66M	5.97M	4.97M	4.73M	4.96M	5.42M	6.23M	7.42M	10.49M	10.54M	8.84M	6.61M	2.25M	25.04K	176.03K	180.13K	171.31K	171.87K	14.76K
Income Tax Expense	895K	1.06M	2.48M	405.99K	-24.01K	-241.01K	104K	129K	284K	258K	-105.53K	-185.56K	-262.33K	-165.91K	32.27K	-18.09K	3.65K	-3.29K	-19.25K	13.19K	8.53K	16.52K	40.62K	34.58K	29.29K	12.82K	29.00	29.00	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	69.64M	69.64M	69.55M	69.64M	63.55M	56.13M	55.55M	54M	53.74M	53.55M	52.21M	49.25M	48.85M	48.34M	36.98M	33.19M	28.8M	28.62M	28.53M	25.01M	24.58M	24.58M	24.47M	24.34M	24.34M	24.31M	24.31M	1.16M	357.14K	357.14K	357.14K	16.25K	332.68K	1.07M
Shares Outstanding (Diluted)	69.64M	69.64M	69.55M	69.64M	63.55M	56.13M	55.55M	54M	53.74M	53.55M	52.21M	49.25M	48.85M	48.34M	36.98M	33.19M	28.8M	28.62M	28.53M	25.01M	24.58M	24.58M	24.47M	24.34M	24.34M	24.31M	24.31M	1.16M	357.14K	357.14K	357.14K	16.25K	332.68K	1.07M
EPS (Basic)	-0.2	-0.17	-0.2	-0.17	-0.24	-0.37	-0.42	-0.47	-0.49	-0.42	-0.35	-0.31	-0.27	-0.26	-0.26	-0.22	-0.22	-0.19	-0.18	-0.2	-0.22	-0.26	-0.31	-0.43	-2.22	-2.2	-2.14	-2	-0.16	-0.58	-0.56	-0.52	-0.48	-0.01
EPS (Diluted)	-0.2	-0.17	-0.2	-0.17	-0.24	-0.37	-0.42	-0.47	-0.49	-0.42	-0.35	-0.31	-0.27	-0.26	-0.26	-0.22	-0.22	-0.19	-0.18	-0.2	-0.22	-0.26	-0.31	-0.43	-2.22	-2.2	-2.14	-2	-0.16	-0.58	-0.56	-0.52	-0.48	-0.01
EBITDA	-19.14M	-17.06M	-15.68M	-17.09M	-17.13M	-20.66M	-22.35M	-24.8M	-24.99M	-20.58M	-17.15M	-14.21M	-11.47M	-9.5M	-8.2M	-6.64M	-5.93M	-4.94M	-4.71M	-4.94M	-5.4M	-6.21M	-7.37M	-10.42M	-10.47M	-8.79M	-6.58M	-2.24M	-591.22K	-742.2K	-746.3K	-737.48K	-171.87K	-14.76K
EBIT	-2.85M	-4.39M	-4.39M	-2.69M	-1.55M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.19M	-2.19M	-2.19M	-2.19M	-565.79K	-565.79K	-565.79K	-565.79K	n/a	n/a
Depreciation & Amortization	4K	5K	45.58K	52.58K	61.58K	69.58K	38K	41K	41K	39.92K	40K	33.18K	24.42K	16.73K	7.89K	5.41K	5.88K	6.35K	6.82K	6.82K	6.82K	6.82K	9.7K	9.23K	10.31K	8.6K	4.01K	2.78K	0.18	0.18	0.18	0.18	n/a	n/a